About Emerald BioSystems
Emerald BioSystems is a Healthcare company based in Bainbridge Island (United States) founded in 1998, and was acquired by Beryllium in November 2009. Laboratory automation, bioinformatics software, reagent kits and plastic-ware products. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is Emerald BioSystems Holding Co., Inc. Its competitors include Cyrus Biotechnology, Vividion Therapeutics and Seer; 3 of its 3 listed competitors have raised funding.
Company details
Emerald BioSystems was founded in 1998 in Bainbridge Island, United States, within the biotechnology sector focused on structural biology. Tools such as laboratory automation systems, bioinformatics software, reagent kits, and plastic-ware were supplied to support gene-to-protein-structure workflows. Automated cell-free protein expression, purification, and crystallization processes were enabled by these solutions, including the Microcapillary Protein Crystallization System and CrystalCards for microfluidic applications. Acquisition by Beryllium took place in November 2009.
- Headquarters Bainbridge Island, United States
- Stage Acquired
- SectorsHealthcare
- Website emeraldbiosystems.com
- Social LinkedIn X
- Acquired by Beryllium (Nov 2009)
- Legal Name Emerald Biosystems Holding Co., Inc.
Investors in Emerald BioSystems
Emerald BioSystems has secured backing from 1 investor. Prominent investors backing the company include Be4.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Drug discovery solutions are offered by Beryllium through specialized services. | 2009 | be4.com | Bedford, United Kingdom |
Investor details for Emerald BioSystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Emerald BioSystems
2 dated milestones of Emerald BioSystems across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Emerald BioSystems is founded.
- Exit Acquired by Beryllium.
Competitors of Emerald BioSystems
Emerald BioSystems has 3 listed competitors in our database, 3 of them funded. They include Cyrus Biotechnology, Vividion Therapeutics and Seer.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| cyrusbio.com | 2014 | Seattle, United States | $31.99M | 23 | Cloud-based protein-modeling software is developed for drug discovery. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| seer.bio | 2017 | San Francisco, United States | $127.5M | 89 | Proteomics platform developed for early cancer and neurological disease detection. |
Detailed competitors of Emerald BioSystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Emerald BioSystems (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Emerald BioSystems
Emerald BioSystems was founded in 1998.
Emerald BioSystems is headquartered in Bainbridge Island, United States. It is registered at Bainbridge Island, Washington, United States.
Emerald BioSystems was founded in 1998 in Bainbridge Island, United States, within the biotechnology sector focused on structural biology. Tools such as laboratory automation systems, bioinformatics software, reagent kits, and plastic-ware were supplied to support gene-to-protein-structure workflows. Automated cell-free protein expression, purification, and crystallization processes were enabled by these solutions, including the Microcapillary Protein Crystallization System and CrystalCards for microfluidic applications. Acquisition by Beryllium took place in November 2009.
Emerald BioSystems's top competitors include Vividion Therapeutics, Cyrus Biotechnology and Seer.
Emerald BioSystems has 1 investor. Key investors include Be4.
Emerald BioSystems operates through Emerald Biosystems Holding Co., Inc..
Yes. Emerald BioSystems was acquired by Beryllium in November 2009.